T2 Biosystems Inc (TTOO)
6.03
+0.39
(+6.91%)
USD |
NASDAQ |
May 20, 16:00
6.03
0.00 (0.00%)
After-Hours: 16:55
T2 Biosystems Free Cash Flow: -46.88M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -46.88M |
| December 31, 2023 | -48.33M |
| September 30, 2023 | -49.25M |
| June 30, 2023 | -51.87M |
| March 31, 2023 | -49.56M |
| December 31, 2022 | -50.97M |
| September 30, 2022 | -50.64M |
| June 30, 2022 | -44.30M |
| March 31, 2022 | -44.90M |
| December 31, 2021 | -39.33M |
| September 30, 2021 | -38.42M |
| June 30, 2021 | -35.27M |
| March 31, 2021 | -38.12M |
| December 31, 2020 | -44.02M |
| September 30, 2020 | -45.04M |
| June 30, 2020 | -52.33M |
| March 31, 2020 | -47.87M |
| December 31, 2019 | -46.12M |
| September 30, 2019 | -45.31M |
| June 30, 2019 | -41.93M |
| March 31, 2019 | -41.99M |
| Date | Value |
|---|---|
| December 31, 2018 | -40.73M |
| September 30, 2018 | -42.35M |
| June 30, 2018 | -43.70M |
| March 31, 2018 | -47.64M |
| December 31, 2017 | -50.19M |
| September 30, 2017 | -50.43M |
| June 30, 2017 | -51.42M |
| March 31, 2017 | -52.29M |
| December 31, 2016 | -51.93M |
| September 30, 2016 | -51.43M |
| June 30, 2016 | -51.82M |
| March 31, 2016 | -50.58M |
| December 31, 2015 | -45.44M |
| September 30, 2015 | -44.28M |
| June 30, 2015 | -39.14M |
| March 31, 2015 | -33.07M |
| December 31, 2014 | -30.27M |
| September 30, 2014 | -25.38M |
| June 30, 2014 | -22.33M |
| March 31, 2014 | -20.64M |
| December 31, 2013 | -18.57M |
Free Cash Flow Range, Past 5 Years
-52.33M
Minimum
Jun 2020
-35.27M
Maximum
Jun 2021
-45.52M
Average
-45.72M
Median
Free Cash Flow Benchmarks
| Abeona Therapeutics Inc | -40.64M |
| Nortech Systems Inc | 1.347M |
| INVO Bioscience Inc | -5.200M |
| SINTX Technologies Inc | -12.44M |
| Tactile Systems Technology Inc | 34.59M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.68M |
| Cash from Financing (Quarterly) | 2.202M |
| Free Cash Flow Per Share (Quarterly) | -2.293 |
| Free Cash Flow to Equity (Quarterly) | -12.06M |
| Free Cash Flow Yield | -215.4% |